11/21
04:11 pm
jnj
Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy [Yahoo! Finance]
Low
Report
Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy [Yahoo! Finance]
11/21
02:08 pm
jnj
Dr Oz nominated to lead CMS despite big pharma ties [Yahoo! Finance]
Low
Report
Dr Oz nominated to lead CMS despite big pharma ties [Yahoo! Finance]
11/21
09:57 am
jnj
Ophthalmic Equipment Market Size to Hit USD 105.20 Billion by 2033 | Straits Research [Yahoo! Finance]
Low
Report
Ophthalmic Equipment Market Size to Hit USD 105.20 Billion by 2033 | Straits Research [Yahoo! Finance]
11/21
09:10 am
jnj
EcoVadis' Coupa Connector Empowers Procurement Teams to Embed Sustainability into Every Purchasing Decision [Yahoo! Finance]
Low
Report
EcoVadis' Coupa Connector Empowers Procurement Teams to Embed Sustainability into Every Purchasing Decision [Yahoo! Finance]
11/21
08:00 am
jnj
Which Is A Better Pick: JNJ Stock Or AbbVie? [Forbes]
Low
Report
Which Is A Better Pick: JNJ Stock Or AbbVie? [Forbes]
11/20
04:52 pm
jnj
Dr. Oz Held Millions In Healthcare Investments, Raising Potential Conflicts For Medicare And Medicaid [Forbes]
Low
Report
Dr. Oz Held Millions In Healthcare Investments, Raising Potential Conflicts For Medicare And Medicaid [Forbes]
11/20
07:07 am
jnj
Seaport Therapeutics Adds Sandi Peterson to its Board of Directors [Yahoo! Finance]
Low
Report
Seaport Therapeutics Adds Sandi Peterson to its Board of Directors [Yahoo! Finance]
11/20
05:15 am
jnj
Bitcoin Nears $94K Milestone as Market Cap Hits $1.85 Trillion Amid ETF Options and Liquidity Hunt [Yahoo! Finance]
Low
Report
Bitcoin Nears $94K Milestone as Market Cap Hits $1.85 Trillion Amid ETF Options and Liquidity Hunt [Yahoo! Finance]
11/19
06:41 pm
jnj
Surgical Sutures Market Report: Key Insights and Projections | Exactitude Consultancy [Yahoo! Finance]
Low
Report
Surgical Sutures Market Report: Key Insights and Projections | Exactitude Consultancy [Yahoo! Finance]
11/19
05:13 pm
jnj
Meet Wall Street billionaire Howard Lutnick, Donald Trump's nominee for commerce secretary [Business Insider]
Low
Report
Meet Wall Street billionaire Howard Lutnick, Donald Trump's nominee for commerce secretary [Business Insider]
11/19
10:51 am
jnj
Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive [Seeking Alpha]
Low
Report
Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive [Seeking Alpha]
11/19
09:22 am
jnj
Healthcare executives expect more IPOs and corporate dealmaking in 2025 [Yahoo! Finance Canada]
Low
Report
Healthcare executives expect more IPOs and corporate dealmaking in 2025 [Yahoo! Finance Canada]
11/19
09:21 am
jnj
Healthcare executives expect more IPOs and corporate dealmaking in 2025 [Yahoo! Finance]
Low
Report
Healthcare executives expect more IPOs and corporate dealmaking in 2025 [Yahoo! Finance]
11/19
09:14 am
jnj
Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting [Yahoo! Finance]
Low
Report
Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting [Yahoo! Finance]
11/19
09:02 am
jnj
Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
Low
Report
Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
11/19
08:31 am
jnj
Stornaway Voyager Transforms Static Video Content into Dynamic Visual Journeys and Gamified Experiences [Yahoo! Finance]
Low
Report
Stornaway Voyager Transforms Static Video Content into Dynamic Visual Journeys and Gamified Experiences [Yahoo! Finance]
11/19
08:08 am
jnj
Biolojic Design Joins Johnson & Johnson Innovation - JLABS [Yahoo! Finance]
Low
Report
Biolojic Design Joins Johnson & Johnson Innovation - JLABS [Yahoo! Finance]
11/19
05:39 am
jnj
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis [Yahoo! Finance]
Low
Report
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis [Yahoo! Finance]
11/19
02:06 am
jnj
Nouscom Completes Patient Enrollment of Randomized Phase 2 Study Evaluating NOUS-209, an Off-the-Shelf Neoantigen Immunotherapy, in dMMR/MSI Metastatic Colorectal Cancer [Yahoo! Finance]
Low
Report
Nouscom Completes Patient Enrollment of Randomized Phase 2 Study Evaluating NOUS-209, an Off-the-Shelf Neoantigen Immunotherapy, in dMMR/MSI Metastatic Colorectal Cancer [Yahoo! Finance]
11/18
04:35 pm
jnj
Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results [Yahoo! Finance]
Low
Report
Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results [Yahoo! Finance]
11/18
04:30 pm
jnj
Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results
Low
Report
Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results
11/18
03:31 pm
jnj
The PFA race is heating up. Here's where the market stands after J&J's approval. [Yahoo! Finance]
Low
Report
The PFA race is heating up. Here's where the market stands after J&J's approval. [Yahoo! Finance]
11/17
11:54 am
jnj
More from CNN [CNN]
Low
Report
More from CNN [CNN]
11/17
11:34 am
jnj
How a decades-old unsolved murder case changed the way we consume medicine [CNN]
Low
Report
How a decades-old unsolved murder case changed the way we consume medicine [CNN]
11/15
10:19 am
jnj
CHMP recommends RYBREVANT®? (amivantamab) in combination with LAZCLUZE®? (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer [Yahoo! Finance]
Low
Report
CHMP recommends RYBREVANT®? (amivantamab) in combination with LAZCLUZE®? (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer [Yahoo! Finance]